138 related articles for article (PubMed ID: 34558189)
1. Prognostic factors for patients with relapsed central nervous system nongerminomatous germ cell tumors.
Abu-Arja MH; Osorio DS; Lassaletta A; Graham RT; Coven SL; Stanek JR; Bouffet E; Finlay JL; Abdelbaki MS
Pediatr Blood Cancer; 2022 Jan; 69(1):e29365. PubMed ID: 34558189
[TBL] [Abstract][Full Text] [Related]
2. Optimal radiotherapy target volumes in intracranial nongerminomatous germ cell tumors: Long-term institutional experience with chemotherapy, surgery, and dose- and field-adapted radiotherapy.
Breen WG; Blanchard MJ; Rao AN; Daniels DJ; Buckner JC; Laack NNI
Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28695992
[TBL] [Abstract][Full Text] [Related]
3. Critical review of the management of primary central nervous nongerminomatous germ cell tumors.
Abu Arja MH; Bouffet E; Finlay JL; AbdelBaki MS
Pediatr Blood Cancer; 2019 Jun; 66(6):e27658. PubMed ID: 30767415
[TBL] [Abstract][Full Text] [Related]
4. A Phase 2 Trial of Response-Based Radiation Therapy for Localized Central Nervous System Germ Cell Tumors: Patterns of Failure and Radiation Dosimetry for Nongerminomatous Germ Cell Tumors.
Murphy ES; Dhall G; Fangusaro J; Bartels U; Fouladi M; Shaw D; Khatua S; Hughes CW; Panigraphy A; Ioakeim-Ioannidou M; Souweidane M; Morris D; Gajjar A; Wu S; Onar-Thomas A; Haas-Kogan DA; MacDonald SM
Int J Radiat Oncol Biol Phys; 2022 May; 113(1):143-151. PubMed ID: 34990779
[TBL] [Abstract][Full Text] [Related]
5. Myeloablative chemotherapy and autologous stem cell transplantation in patients with relapsed or progressed central nervous system germ cell tumors: results of Korean Society of Pediatric Neuro-Oncology (KSPNO) S-053 study.
Baek HJ; Park HJ; Sung KW; Lee SH; Han JW; Koh KN; Im HJ; Kang HJ; Park KD
J Neurooncol; 2013 Sep; 114(3):329-38. PubMed ID: 23824533
[TBL] [Abstract][Full Text] [Related]
6. Phase II Trial of Response-Based Radiation Therapy for Patients With Localized CNS Nongerminomatous Germ Cell Tumors: A Children's Oncology Group Study.
Fangusaro J; Wu S; MacDonald S; Murphy E; Shaw D; Bartels U; Khatua S; Souweidane M; Lu HM; Morris D; Panigrahy A; Onar-Thomas A; Fouladi M; Gajjar A; Dhall G
J Clin Oncol; 2019 Dec; 37(34):3283-3290. PubMed ID: 31545689
[TBL] [Abstract][Full Text] [Related]
7. Secreting germ cell tumors of the central nervous system (CNS). First results of the cooperative German/Italian pilot study (CNS sGCT).
Calaminus G; Andreussi L; Garré ML; Kortmann RD; Schober R; Göbel U
Klin Padiatr; 1997; 209(4):222-7. PubMed ID: 9293454
[TBL] [Abstract][Full Text] [Related]
8. Treatment and Outcome of Patients with Stage IS Testicular Cancer: A Retrospective Study from the Spanish Germ Cell Cancer Group.
Aparicio J; Sánchez-Muñoz A; Ochenduszko S; Gumà J; Fernández-Aramburo A; García Del Muro X; Quiroga V; Sastre J; Alonso-Gordoa T; Sagastibelza N; Maroto P; Gómez de Liaño A; Vázquez S; Diz P; Durán I; Domenech M; Pinto A; Hernández A; González-Billalabeitia E; Terrasa J
J Urol; 2019 Oct; 202(4):742-747. PubMed ID: 31163007
[TBL] [Abstract][Full Text] [Related]
9. Delayed surgical resection of central nervous system germ cell tumors.
Weiner HL; Lichtenbaum RA; Wisoff JH; Snow RB; Souweidane MM; Bruce JN; Finlay JL
Neurosurgery; 2002 Apr; 50(4):727-33; discussion 733-4. PubMed ID: 11904022
[TBL] [Abstract][Full Text] [Related]
10. Treatment and outcomes of UK and German patients with relapsed intracranial germ cell tumors following uniform first-line therapy.
Murray MJ; Bailey S; Heinemann K; Mann J; Göbel UK; Saran F; Hale JP; Calaminus G; Nicholson JC
Int J Cancer; 2017 Aug; 141(3):621-635. PubMed ID: 28463397
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of patients with relapsed and refractory germ cell tumors treated with high-dose chemotherapy and autologous bone marrow rescue.
Broun ER; Nichols CR; Kneebone P; Williams SD; Loehrer PJ; Einhorn LH; Tricot GJ
Ann Intern Med; 1992 Jul; 117(2):124-8. PubMed ID: 1318648
[TBL] [Abstract][Full Text] [Related]
12. [Treatment outcome of primary central nervous system germ cell tumors after combined therapy: a report of 23 cases].
Yang QY; Sun XF; Huang HQ; Zhen ZJ; Xia Y; Cai QQ; Ling JY
Ai Zheng; 2008 Apr; 27(4):438-41. PubMed ID: 18423134
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in patients with relapsed or primary refractory germ cell tumors.
Rejlekova K; Mego M; Sycova-Mila Z; Obertova J; Rajec J; Salek T; Mardiak J
Neoplasma; 2009; 56(3):215-23. PubMed ID: 19309224
[TBL] [Abstract][Full Text] [Related]
14. Treatment of recurrent malignant sacrococcygeal germ cell tumors: analysis of 22 patients registered in the German protocols MAKEI 83/86, 89, and 96.
Schneider DT; Wessalowski R; Calaminus G; Pape H; Bamberg M; Engert J; Waag K; Gadner H; Göbel U
J Clin Oncol; 2001 Apr; 19(7):1951-60. PubMed ID: 11283127
[TBL] [Abstract][Full Text] [Related]
15. Outcome of patients with intracranial non-germinomatous germ cell tumors-lessons from the SIOP-CNS-GCT-96 trial.
Calaminus G; Frappaz D; Kortmann RD; Krefeld B; Saran F; Pietsch T; Vasiljevic A; Garre ML; Ricardi U; Mann JR; Göbel U; Alapetite C; Murray MJ; Nicholson JC
Neuro Oncol; 2017 Nov; 19(12):1661-1672. PubMed ID: 29048505
[TBL] [Abstract][Full Text] [Related]
16. Marker (+) CNS germ cell tumors in remission: are surveillance MRI scans necessary?
Martinez S; Khakoo Y; Gilheeney S; Kramer K; Wolden S; Souweidane M; Dunkel IJ
Pediatr Blood Cancer; 2014 May; 61(5):853-4. PubMed ID: 24375894
[TBL] [Abstract][Full Text] [Related]
17. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
18. Relapse and outcome patterns of patients with central nervous system mixed malignant germ cell tumors treated without irradiation: Findings from the third international central nervous system (CNS) germ cell tumor (GCT) study.
Pruitt R; DaSilva NS; Cappellano A; Belessiotis C; Diez B; Gardner S; Allen J; Weinblatt M; Gottardo N; Dhall G; Finlay JL
Pediatr Blood Cancer; 2015 Nov; 62(11):1920-4. PubMed ID: 26054044
[TBL] [Abstract][Full Text] [Related]
19. Multimodality therapy for CNS mixed malignant germ cell tumors (MMGCT): results of a phase II multi-institutional study.
Robertson PL; Jakacki R; Hukin J; Siffert J; Allen JC
J Neurooncol; 2014 May; 118(1):93-100. PubMed ID: 24700239
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of tumor size, metastases, extension into bone, and increased tumor marker in children with malignant sacrococcygeal germ cell tumors: a prospective evaluation of 71 patients treated in the German cooperative protocols Maligne Keimzelltumoren (MAKEI) 83/86 and MAKEI 89.
Calaminus G; Schneider DT; Bökkerink JP; Gadner H; Harms D; Willers R; Göbel U
J Clin Oncol; 2003 Mar; 21(5):781-6. PubMed ID: 12610174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]